entertainment -WSS

entertainment

author：comprehensive 2025-09-28 16:35:11 - browse：19541

Johnson & Johnson sign — MARK RALSTON/AFP via Getty Images

WASHINGTON — Pharmaceutical giant Johnson & Johnson on Tuesday became the third drugmaker to sue the Biden administration over its new Medicare drug price negotiation program.

J&J joins a flurry of litigation challenging the Medicare drug price negotiation program, which is set to start this fall. Merck, Bristol Myers Squibb, the brand-drug lobby PhRMA, and the U.S. Chamber of Commerce have also filed suit. The negotiated prices would go into effect in 2026.

The company argued that it is entitled to sue because its blockbuster blood thinner drug Xarelto may be up for negotiation in the first round of ten drugs Medicare will examine, but that list is not set to be announced officially until Sept. 1.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： Medicare slashes safety net hospital payments by nearly $1 billion

leisure time

WSS

The cancer stories no one wants to hear

Senate panel clears PBM, hopsital reforms

Medicare slashes safety net hospital payments by nearly $1 billion

Judge partially blocks Texas abortion ban for medical emergencies, fatal diagnoses

Listen: Biotech layoffs, eye drug drama, & gene therapy milestones

How to ethically and practically extend health care to all

hotspot

entertainment

entertainment

Psychedelics group wrestles with new pharma identity

Study: New antibiotic targets gonorrhea as well as last existing drug

Moonlake's readout produced a cash windfall. Risks remain

When waiting feels immoral: Empathy in the emergency department

Medicare proposal to cover medical devices draws a mixed reaction

2 officers injured in shooting in Orlando, police say

Continuity nursing helped my family in our darkest PICU moments

Biotech startup Celsius cuts 75% of staff ahead of first trial start

Wildfire smoke exposes gaps in outdoor worker protections

Physicians aren't 'burning out.' They're suffering from moral injury

Wikipedia

Judge partially blocks Texas abortion ban for medical emergencies, fatal diagnoses

Senate panel clears PBM, hopsital reforms

Ambulance rides for just $100? Advisers want major billing fixes

Free speech concerns arise in wake of journal editor Eisen's firing

Senate panel clears PBM, hopsital reforms

FDA approves Sage Therapeutics’ rapid

leisure time

focus

leisure time

knowledge